Glynis Abron, MD, board-certified dermatologist, clinical associate professor of dermatology at the University of California, Los Angeles, and owner of the Abron Skin Institute and Research Center in Manhattan Beach, will be speaking at the 2024 IMCAS World Congress in Paris, France. I gave a lecture. , California presents her best clinical pearls for hair restoration.
Mr. Abron's session, “Ethics of Hair Loss Treatment,” explores the multifactorial aspects of hair loss, the need for physicians to be aware of all available treatment options, and the latest in research.
“Through scientific research, clinical trials, and data, I think we can evaluate different options to support or refute treatment development and what works for patients,” Abron said.
transcript
Glynis Abron, MD: Hello, this is Dr. Glynis Abron. I am a board-certified dermatologist in Manhattan Beach, California, run the Avron Skin Institute and Research Center, and am an associate professor at UCLA.
Dermatology Times: Could you talk about the significance of the IMCAS conference, which brings together so many world-renowned doctors?
Abron: IMCAS is one of the world's largest medical aesthetic conferences. In fact, cosmetic physicians, dermatologists, and plastic surgeons from all over the world with different backgrounds come together to make scientific contributions, new technologies, new and current trends, and develop companies in an exciting and diverse medical community. Can be shared. .
Dermatology Times: What are the top three things you want participants to take away from the session “Ethics of Hair Loss Treatment”?
Abron: Here are my top 3 takeaways from my session on hair removal. It is important to remember that hair loss is multifactorial and only part of it is due to genetics. It is very important to look for all possible etiologies that may affect a person with alopecia. That includes people exposed to environmental exposures, stress, hormones, and there's so much to discuss. I love patient surveys. Second, as a physician, I would say that many patients come to us knowing what they want, so we need to be aware of all the treatment options that are out there. . So we really need to know what's out there, how it works, number of sessions, pricing, clinical success, complications, etc., and all of that information can help guide the ethical decision-making process for hair removal for each individual patient. provide an approach. Third, understand the research and data about each treatment option and understand that combination treatments are often the most effective and provide the greatest results for those patients. is.
Dermatology Times: Your session is part of the larger “Hair Restoration: Medical” track. How are you and the other presenters providing new data to the dermatology community to best serve patients?
Abron: Several years ago, I recently published an article with Dr. Nester and his team that looked at the ethics of hair removal. That's really important. We have currently completed four clinical trials for hair loss supplements. And like my colleagues, I too can, through scientific research, clinical trials, and data, really evaluate the different options that support or refute treatment development, and what really works for patients. I think it is.
[Transcript lighted edited for space and clarity.]